This bifunctional protein plays a critical role in lysophospholipid acylation. Specifically, it catalyzes the transfer of fatty acids to the 1-position of lysophospholipids via an enzyme-bound acyl-ACP intermediate, requiring ATP and magnesium. Its physiological function is the regeneration of phosphatidylethanolamine from 2-acyl-glycero-3-phosphoethanolamine (2-acyl-GPE), a byproduct of transacylation reactions or phospholipase A1 degradation.
KEGG: ecy:ECSE_3093
The aas protein in Escherichia coli is a bifunctional enzyme that performs two distinct enzymatic activities: 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase and acyl-acyl carrier protein (acyl-ACP) synthetase. These two activities are carried out by the same gene product, as verified through cloning and expression studies . The bifunctional nature of this protein enables it to play a crucial role in phospholipid metabolism, specifically in the acylation of endogenous 2-acyl-GPE and the recycling of membrane lipid components. Research has established that the aas protein is the rate-limiting enzyme in the uptake and incorporation of exogenous 2-acyllysophospholipids into the bacterial membrane .
Regulation likely follows patterns similar to other metabolic enzymes in E. coli, where expression kinetics show that biosynthetic enzymes typically comprise about 15% of cellular proteins during growth in minimal medium . The timing of enzyme expression follows a positive relation between the onset time of enzyme synthesis and the fractional enzyme "reserve" maintained while growing in rich media. This regulatory pattern suggests that aas expression may be upregulated in response to membrane stress or phospholipid precursor depletion .
For successful recombinant expression of the aas protein, the following methodological approach is recommended:
Expression System:
Host: E. coli expression strains (BL21(DE3) or derivatives) are commonly used for expressing bacterial proteins
Vector: Expression vectors containing T7 promoter systems with N-terminal His-tag for purification purposes
Culture Conditions: Growth at 37°C in LB medium until OD600 0.6-0.8, followed by induction with IPTG (0.1-1 mM)
Purification Protocol:
Cell Harvest: Centrifugation at 4000 × g
Cell Lysis: Sonication or pressure-based lysis in buffer containing 20-50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, and protease inhibitors
Clarification: Centrifugation at >15,000 × g for 30 minutes
Affinity Chromatography: Nickel affinity purification using His-tag
Further Purification: Size exclusion chromatography if needed
Quality Control:
Activity Assay: Acyltransferase activity using 2-acyl-GPE substrates
For optimal reconstitution after lyophilization, protein should be dissolved in deionized sterile water to a concentration of 0.1-1.0 mg/mL with 5-50% glycerol as a cryoprotectant .
Measuring the dual enzymatic activities of the aas protein requires distinct assay systems for each function:
2-acyl-GPE Acyltransferase Activity:
In vitro assay using radiolabeled substrates:
Prepare reaction mixture containing:
Purified aas protein (1-10 μg)
Radiolabeled 2-acyl-GPE substrate (typically 14C or 3H labeled)
Acyl donor (acyl-ACP or acyl-CoA)
Buffer: 50 mM Tris-HCl (pH 7.5), 10 mM MgCl2
Incubate at 30°C for 15-30 minutes
Extract lipids using chloroform/methanol (2:1 v/v)
Separate by thin-layer chromatography (TLC)
Acyl-ACP Synthetase Activity:
ATP-PPi exchange assay:
Direct acylation assay:
These methodologies can distinguish between the two activities and allow researchers to study factors affecting each function independently.
The bifunctional aas protein contains distinct structural domains that support its dual enzymatic activities:
Domain Organization:
Comparison of the predicted amino acid sequence with other acyl-CoA synthetases reveals three conserved domains that are postulated to form the acyl-AMP binding pocket . These domains are likely arranged similarly to other bifunctional proteins in E. coli, such as the rfaE gene product, which contains two clearly separated domains with distinct functions .
The functional organization can be inferred to include:
An N-terminal domain responsible for acyl-ACP synthetase activity
A C-terminal domain mediating the 2-acyl-GPE acyltransferase activity
A central region containing the conserved acyl-AMP binding pocket
Domain Interaction Model:
Similar to other bifunctional proteins in E. coli, the domains might function independently but coordinate activities through:
Substrate channeling between active sites
Conformational changes upon substrate binding
Allosteric regulation between domains
Research methodologies to study domain interactions include:
Limited proteolysis to identify domain boundaries
Expression of individual domains to test independent function
Site-directed mutagenesis of residues at domain interfaces
Structural studies using X-ray crystallography or cryo-EM
The rfaE gene example from E. coli demonstrated that its two domains (amino acids 1-318 and 344-477) could be expressed individually with Domain I complementing specific mutations while Domain II remained functionally distinct . This suggests a potential approach for studying aas domain functionality.
The aas protein functions cooperatively with the LplT lysophospholipid transporter in a two-component system for membrane lipid remodeling:
Functional Coordination Mechanism:
LplT translocates lysophospholipids (particularly 2-acyl lyso-PE) from the periplasmic leaflet to the cytoplasmic leaflet of the inner membrane
Aas, located on the cytoplasmic side, reacylates these lysophospholipids to form complete phospholipids
This coordinated process allows for recycling of membrane components and incorporation of exogenous fatty acids
Experimental Evidence of Interaction:
Research has demonstrated this coordination through:
TLC-based LPL translocation assays showing Aas-dependent formation of diacyl lipids from translocated lysophospholipids
Studies with ΔlplT, Δaas, and ΔlplT/aas mutant strains showing defects in lysophospholipid transport and reacylation
Methodological Approach to Study This Interaction:
Preparation of E. coli Spheroplasts:
Culture E. coli WT or ΔlplT, Δaas, and ΔlplT/aas mutant strains
Prepare spheroplasts using the lysozyme-EDTA method
Resuspend in appropriate buffer (spheroplast solution B)
Transport Assay Protocol:
This methodological approach allows researchers to quantitatively assess the functional relationship between LplT and Aas in membrane lipid remodeling.
Isotope labeling provides powerful tools for tracing the fate of substrates in aas-mediated lipid metabolism:
Hydrogen Isotope (δ2H) Labeling Strategy:
Experimental Design:
Analytical Methods:
Gas chromatography-isotope ratio mass spectrometry (GC-IRMS)
Liquid chromatography-mass spectrometry (LC-MS) for compound-specific isotope analysis
Data Interpretation:
Carbon-13 Labeling Approach:
Pulse-Chase Experiments:
Feed E. coli with 13C-labeled fatty acids or lysophospholipids
Monitor incorporation into membrane lipids over time
Quantify the rate and specificity of aas-mediated incorporation
Metabolic Flux Analysis:
Use 13C-labeled glucose and trace carbon flow through central metabolism to lipid biosynthesis
Construct mathematical models to quantify fluxes through aas-dependent pathways
Compare wild-type and aas mutant strains to determine metabolic impact
These isotope labeling strategies provide quantitative insights into aas function that cannot be obtained through conventional biochemical methods.
Multiple complementary approaches can be employed to study aas function in living cells:
Gene Deletion and Complementation:
Generate Δaas knockout strain using CRISPR-Cas9 or recombineering techniques
Characterize phenotypic changes in membrane composition and integrity
Complement with wild-type or mutant versions of aas to restore function
Quantify restoration of phenotype to determine critical residues for function
Site-Directed Mutagenesis:
Introduce point mutations in conserved domains
Express mutant proteins and assess impact on:
Chemoproteomics Approaches:
Based on chemoproteomic-detected amino acids (CpDAA) methodology:
Detect reactive residues in aas using activity-based protein profiling
Map these residues to genomic coordinates
Correlate with predicted pathogenicity scores to identify functionally critical residues
Fluorescent Protein Fusions:
Generate C- or N-terminal GFP fusions with aas
Visualize subcellular localization under various conditions
Perform FRAP (Fluorescence Recovery After Photobleaching) to study membrane dynamics
These approaches provide comprehensive insights into aas function in living cells, connecting molecular mechanisms to physiological roles.
The aas protein plays significant roles in bacterial stress responses, particularly those affecting membrane integrity:
Acid Stress Response:
Acid resistance (AR) studies in E. coli have shown that membrane lipid composition affects survival in acidic environments. The aas protein, by maintaining proper membrane phospholipid composition, likely contributes to acid resistance mechanisms. Methodological approaches to study this include:
Exposing wild-type and Δaas mutant strains to acetic acid solutions (AAS) at pH 3.2
Measuring survival rates with or without glutamic acid supplementation
Correlating membrane phospholipid composition with acid resistance profiles
Membrane Stress Response:
During stress conditions that activate phospholipases (e.g., detergent-resistant PldA phospholipase A1), aas functions to:
Reacylate the resulting lysophospholipids to maintain membrane integrity
Prevent accumulation of potentially detergent-like lysophospholipids
Recycle fatty acids released during stress-induced phospholipid turnover
Metabolic Adaptation:
The aas protein's role in incorporating exogenous fatty acids provides metabolic flexibility during nutrient limitation. Studies have shown:
Strains with multiple copies of the aas gene show higher specific activities for incorporation of exogenous fatty acids and lysophospholipids
This may provide adaptive advantages in environments with available lipid materials
Research Methodology for Stress Studies:
To study aas function during stress:
Subject wild-type and Δaas strains to various stresses (acid, osmotic, oxidative)
Monitor changes in membrane composition using lipidomics
Measure stress-specific marker expression (e.g., stress-response genes)
Assess phenotypic outcomes such as growth rate, survival, and membrane permeability
Understanding these stress-response functions could lead to applications in engineering more robust bacterial strains for biotechnological applications.
Based on experimental protocols for studying aas and similar bifunctional enzymes, the following buffer conditions are recommended:
Storage Buffer Composition:
Tris/PBS-based buffer, pH 8.0
6% Trehalose as stabilizer
50% Glycerol for long-term stability
Reconstitution Protocol:
Briefly centrifuge the vial prior to opening
Reconstitute in deionized sterile water to 0.1-1.0 mg/mL
Add glycerol to 5-50% final concentration (50% recommended)
Aliquot for long-term storage at -20°C/-80°C
Activity Assay Buffer:
For acyltransferase activity:
50 mM Tris-HCl, pH 7.5
10 mM MgCl₂
1-2 mM DTT (to maintain reduced state)
0.1% Triton X-100 (optional, to facilitate substrate accessibility)
For acyl-ACP synthetase activity:
Stability Considerations:
Working aliquots can be stored at 4°C for up to one week
Repeated freezing and thawing significantly reduces activity
Activity is maintained best when stored in buffer containing reducing agents and glycerol
These buffer conditions are critical for maintaining the dual enzymatic activities of the aas protein during in vitro studies.
Developing a comprehensive kinetic model for aas activity presents several challenges that must be addressed using advanced computational and experimental approaches:
Core Challenges in Kinetic Modeling:
Dual Enzymatic Activities:
Integration with Genome-Scale Models:
Parameter Estimation:
Methodological Approach for Kinetic Modeling:
Parameter Determination:
Conduct in vitro steady-state kinetic assays for both enzymatic activities
Determine kcat and Km values for all substrates
Measure product inhibition constants and regulatory effects
Model Construction:
Develop separate rate equations for each enzymatic activity
Incorporate allosteric regulation and feedback inhibition
Link models through shared metabolites and cofactors
Model Validation:
Test predictions against experimental measurements in wild-type E. coli
Validate using mutant strains with altered aas expression
Iteratively refine parameters to improve prediction accuracy
Integration with Whole-Cell Models: